An analytical study on the relationship between the skin microbiome distribution and the phenotype of skin aging
- Conditions
- Not Applicable
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
(1) Women over the age of 19
(2) Subjects who have consented to the provision of samples for human-derived materials
(3) Subjects who voluntarily consented to this study and filled out the consent form
(4) Those who can be followed up during the test period
(1) Subjects with accompanying skin diseases (atopic dermatitis, psoriasis, acne, etc.)
(2) Subjects who have taken systemic antibiotics or antifungals within six months
(3) Subjects who have used topical agents (steroids, antibiotics, antifungals, etc.) within seven days at the site to be tested
(4) Patients with systemic conditions accompanied by instability of vital signs such as infection or organ failure
(5) Those who show skin damage or local infection at the measurement site
(6) Subjects who did not consent to the provision of human-derived specimens
(7) Subjects who did not voluntarily consent to this study and did not fill out the consent form
(8) Vulnerable subjects (including persons with disabilities, insufficient medical ability, pregnant women, newborns, minors, staff in the research department's department, persons confined in facilities, etc.)
(9) Subjects who cannot read and understand the consent form (illiteracy, etc.)
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the relationship between the skin microbiome distribution and the phenotype of skin aging
- Secondary Outcome Measures
Name Time Method skin biophysical parameters